These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dimerization of VEGF receptors and implications for signal transduction: a computational study. Mac Gabhann F; Popel AS Biophys Chem; 2007 Jul; 128(2-3):125-39. PubMed ID: 17442480 [TBL] [Abstract][Full Text] [Related]
7. Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Ruch C; Skiniotis G; Steinmetz MO; Walz T; Ballmer-Hofer K Nat Struct Mol Biol; 2007 Mar; 14(3):249-50. PubMed ID: 17293873 [TBL] [Abstract][Full Text] [Related]
9. Discovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays. Landry JP; Fei Y; Zhu X; Ke Y; Yu G; Lee P Assay Drug Dev Technol; 2013 Jun; 11(5):326-32. PubMed ID: 23772553 [TBL] [Abstract][Full Text] [Related]
10. Hydrazino-Pictet-Spengler ligation as a biocompatible method for the generation of stable protein conjugates. Agarwal P; Kudirka R; Albers AE; Barfield RM; de Hart GW; Drake PM; Jones LC; Rabuka D Bioconjug Chem; 2013 Jun; 24(6):846-51. PubMed ID: 23731037 [TBL] [Abstract][Full Text] [Related]
11. Selection of a high-affinity WW domain against the extracellular region of VEGF receptor isoform-2 from a combinatorial library using CIS display. Patel S; Mathonet P; Jaulent AM; Ullman CG Protein Eng Des Sel; 2013 Apr; 26(4):307-15. PubMed ID: 23378640 [TBL] [Abstract][Full Text] [Related]
16. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling. Thieltges KM; Avramovic D; Piscitelli CL; Markovic-Mueller S; Binz HK; Ballmer-Hofer K Angiogenesis; 2018 Aug; 21(3):533-543. PubMed ID: 29502220 [TBL] [Abstract][Full Text] [Related]
18. Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry. Lees A; Sen G; LopezAcosta A Vaccine; 2006 Feb; 24(6):716-29. PubMed ID: 16233938 [TBL] [Abstract][Full Text] [Related]
19. A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2. Tseng FJ; Chen YC; Lin YL; Tsai NM; Lee RP; Chung YS; Chen CH; Liu YK; Huang YS; Hwang CH; Lai YK; Liao KW Cancer Biol Ther; 2010 Nov; 10(9):865-73. PubMed ID: 20818186 [TBL] [Abstract][Full Text] [Related]
20. Oxime conjugation in protein chemistry: from carbonyl incorporation to nucleophilic catalysis. Agten SM; Dawson PE; Hackeng TM J Pept Sci; 2016 May; 22(5):271-9. PubMed ID: 27006095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]